| Thymus Epithelial Neoplasm studied in …STUDIED_INderived136 of 136show fewer |
|---|
| → studied in | NCT01242072Phase 1 · completed Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02146170recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076554Phase 2 · active not recruiting A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980077Phase 2 · recruiting Ivonescimab for the Treatment of Thymic Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968315NA · active not recruiting An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Malignant Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824505Phase 2 · completed Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05150210NA · active not recruiting SP Thoracic IDE Study · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06248515Phase 2 · recruiting A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950572recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04417660Phase 2 · active not recruiting Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05104736Phase 2 · recruiting PT-112 in Subjects With Thymoma and Thymic Carcinoma · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07324629Phase 2 · recruiting Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03463460Phase 2 · active not recruiting Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750353Phase 2 · not yet recruiting A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01025089Phase 2 · active not recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295227Phase 1 · recruiting Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693855NA · not yet recruiting Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691619Phase 2 · recruiting Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649187NA · completed Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07598955Phase 1/Phase 2 · recruiting Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03134118Phase 2 · active not recruiting Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma Type B3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06019468Phase 2 · recruiting Neoadjuvant Treatment For Locally Advanced Thymic Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07571525not yet recruiting Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633514Phase 3 · withdrawn Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402708Phase 3 · recruiting Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633553NA · recruiting Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375267Phase 1 · completed 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479628Phase 2 · not yet recruiting Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04710628Phase 2 · completed Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383142NA · not yet recruiting Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328074not yet recruiting Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07343453Phase 2 · not yet recruiting A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544929Phase 1 · active not recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385722enrolling by invitation Molecular Analysis of Thoracic Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838910Phase 2 · recruiting Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694002Phase 2 · completed Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179341NA · completed Survival Nomogram for Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186726Phase 2 · recruiting Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06311955Phase 2 · recruiting Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06311968Phase 2 · recruiting The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05667948recruiting Molecular Analysis and Treatment Options of Thymic Malignancies · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05255965completed IL-8+ naïve T Cells as a Biomarker for Thymoma Identification · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730308Phase 2 · recruiting Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692062NA · recruiting Hypofractionated Radiotherapy for Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654830Phase 2 · not yet recruiting RATT Vs. VATT for Early-stage TETs · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583086Phase 1/Phase 2 · completed Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306045Phase 2 · completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621568Phase 2 · completed Sunitinib for Advanced Thymus Cancer Following Earlier Treatment · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05214612unknown Predictors and Prognostic Factors of Myasthenia Gravis Outcome · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523582recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072393NA · terminated Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04321330Phase 2 · completed A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05682742NA · active not recruiting Clinical Investigation of the da Vinci Surgical System · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03921671Phase 2 · unknown Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421805recruiting Establishing Prospective Mediastinal Tumor Database of PUMCH · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925947Phase 2 · terminated A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200233Phase 2 · not yet recruiting Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06301945recruiting Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469725Phase 2 · terminated KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029621NA · recruiting Robot-assisted vs VATS for Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455840NA · unknown A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662645NA · completed Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832827Phase 2 · recruiting First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06086327early Phase 1 · unknown Application of 68Ga-Pentixafor PET/CT for Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06010277Phase 4 · unknown Folinic Acid for Prevention of Pemetrexed-induced Toxicity · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010257Phase 2 · completed Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003283Phase 2 · completed Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724696unknown French National Observatory of Patients With Thymic Epithelial Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05816694Phase 2 · unknown The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train. · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04667793Phase 2 · unknown Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04276597Phase 2 · withdrawn Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193437Phase 2 · terminated Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430842Phase 1 · completed Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162691unknown Single Cell Sequencing Analysis of Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517488Phase 1 · completed A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01272817NA · completed Nonmyeloablative Allogeneic Transplant · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001113NA · completed Surgery for Masaoka-Koga I-II Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05446935NA · unknown Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049047Phase 2 · completed Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307500Phase 2 · completed Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma Type B3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04371458Phase 1/Phase 2 · withdrawn Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023319Phase 1 · completed Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05407649Phase 2 · unknown Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05262582NA · unknown Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220855Phase 2 · completed A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03663764Phase 2 · unknown Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05061784completed Routine Transcervical Thymectomy in MEN-1 Patients · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449173Phase 2 · unknown Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) · condition mapped PROBABILISTIC · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03613272NA · unknown The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03858582Phase 2 · unknown neoadjuvant_thymic Epithelial Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614818unknown A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554524Phase 4 · unknown Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577495completed Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522687recruiting Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517539Phase 2 · unknown Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02014805Phase 3 · unknown Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01102192completed The Role of the Thymus in Myasthenia Gravis · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02607631Phase 2 · completed A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00921739Phase 1 · completed Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143545Phase 1 · terminated Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02636556NA · completed Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364076Phase 2 · unknown Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258868Phase 1 · terminated Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02062632Phase 2 · terminated Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00198133Phase 2 · completed Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01364727Phase 2 · completed A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011439Phase 2 · terminated Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01301391Phase 2 · terminated Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Malignant Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02623127Phase 2 · completed A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02948855withdrawn Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03466827Phase 2 · unknown Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03290183unknown Confocal Laser Endomicroscopy in Pleural Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03288662NA · completed Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100944Phase 1/Phase 2 · terminated A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212027unknown Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging · condition mapped ALIAS · 136 trials mapped (49 active) | — | — | Thymus Epithelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170804unknown Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00332969Phase 2 · completed Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03078699NA · completed Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00965250Phase 2 · completed Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589290Phase 2 · completed Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718809Phase 2 · terminated Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387868Phase 2 · completed Preoperative Treatment of Patients With High Risk Thymoma · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00314873Phase 1 · completed Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369889Phase 2 · completed A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00818090Phase 2 · terminated Paclitaxel and Cisplatin for Thymic Neoplasm · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003662Phase 2 · completed Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases · condition mapped CURATED_BROADER · 136 trials mapped (49 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00965627completed Biology of Thymic Tumors · condition mapped ONTOLOGY_EXACT · 136 trials mapped (49 active) | — | — | Thymoma | 1 | Observed | clinicaltrials | graph → |